新抗原免疫性景观和瘤生态系统的演变与nivolumab免疫治疗期间的nivolumab
Tyler J Alban1,2, Nadeem Riaz3, Prerana Parthasarathy1,2
1Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.
Nature medicine
|September 30, 2024
概括
在非小细胞肺癌中,用尼沃卢马布阻断免疫检查点对免疫原性新抗原进行选择,影响治疗反应. 了解新抗原特征可以提高治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症基因组学 癌症基因组学
背景情况:
- 免疫检查点阻塞 (ICB) 的有效性是由新抗原免疫编辑驱动的,但新抗原特征及其在治疗反应中的作用尚未完全理解.
- 尼沃卢马布是一种免疫检查点抑制剂,用于癌症治疗,特别是非小细胞肺癌 (NSCLC).
- 新抗原是瘤特异性抗原,可以引起免疫反应,使它们成为癌症免疫治疗的关键标.
研究的目的:
- 为了研究新抗原的分子特征及其在非小细胞肺癌患者治疗nivolumab.
- 了解新抗原免疫编辑如何影响免疫检查点封锁的有效性.
- 确定与T细胞识别和临床反应相关的新抗原的特定特征.
主要方法:
- 在nivolumab治疗前和期间,对80名非小细胞肺癌患者在CheckMate 153试验中的活检样本进行分析.
- 对1453个候选新抗原的检查,评估它们的癌细胞分数和T细胞识别.
- 将新抗原映射到克隆动态,进化轨迹和临床反应数据.
主要成果:
- 在nivolumab治疗期间早期失去了突变和新抗原,与临床益处相关.
- 鉴定了T细胞识别的196种新,对免疫性新抗原携带克隆具有强烈的选择性.
- 确定了与免疫性相关的位置特异性氨基酸和生理化学特征,导致免疫性得分的发展.
- 与黑色素瘤相比,NSCLC中尼沃卢马布诱导的瘤微环境演变显示出相似之处和差异.
结论:
- 新抗原免疫编辑对尼沃卢马布在非小细胞肺癌中的疗效起着至关重要的作用.
- 该研究提供了对新抗原景观及其在ICB期间的演变的详细分子见解.
- 识别免疫性新抗原特征可以为开发更有效的癌症免疫疗法提供信息.
更多相关视频
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345


